Jae Yeon Kim

Title: **Innovative Contributions of Jae Yeon Kim**

Introduction

Jae Yeon Kim, an inventor hailing from Yongin-si, South Korea, has made significant strides in the field of pharmaceuticals with his innovative work. His efforts have culminated in a patented invention that showcases the potential for advanced treatments in various medical conditions.

Latest Patents

His notable patent is titled *Crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising same*. This invention addresses a novel crystalline form of a compound that demonstrates excellent stability in high-temperature and humidity environments. The pharmaceutical composition is particularly promising for the prevention and treatment of critical diseases such as thrombosis, myocardial infarction, atherosclerosis, inflammation, stroke, angina pectoris, restenosis after angioplasty, and thromboembolism.

Career Highlights

Jae Yeon Kim has contributed his expertise to reputable organizations, including the Green Cross Corporation and Legochem Biosciences, Inc. His work in these companies illustrates his commitment to advancing pharmaceutical science and his focus on developing effective treatments.

Collaborations

In his professional journey, Jae Yeon Kim has collaborated with notable coworkers such as Soongyu Choi and Jungsub Choi. These partnerships highlight the importance of teamwork and shared knowledge in the realm of innovation and invention.

Conclusion

Jae Yeon Kim is a distinguished inventor whose contributions to the pharmaceutical field have the potential to save lives and improve health outcomes. Through his innovative patent and collaborations, he continues to pave the way for advancements that can significantly impact modern medicine.